Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bombardieri

Showing results (31-40 of 231) with videos related to

Pageof 24
Sort By:
The International Journal of Biological Markers|April 1, 1997
Cost-effectiveness of tumor marker detection in cancer patientsE Bombardieri, S Massaron, A Martinetti, et al.
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1995
Tumour marker evaluation in patients with lung cancerE Seregni, C Botti, A Bogni, et al.
Minerva Medica|September 15, 1975
[Possibilities and limitations of the direct radioimmunological method with double guinea-pig antibody in the detection of serum Australia antigen]A Rodari, R Ringhini, M Parodi, et al.
Tumori|March 1, 1997
The need of cost-effectiveness evaluation when using high-cost equipment in national health servicesE Bombardieri, F Crippa, C Rossetti, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|August 10, 2000
Role of 131I-metaiodobenzylguanidine (MIBG) in the treatment of neuroendocrine tumours. Experience of the National Cancer Institute of MilanM R Castellani, A Chiti, E Seregni, et al.
La Radiologia Medica|September 1, 1977
[Use of bleomycin labeled with In-111 in the diagnosis of neoplasms]A Rodari, A Turrin, E Bombardieri, et al.
La Radiologia Medica|November 1, 1980
[111-In-bleomycin as a positive indicator: evaluation of results in 252 cases controlled by histological diagnosis]E Bombardieri, A Rodari, A Turrin, et al.
La Radiologia Medica|April 6, 1999
[External exposure of hot cell operators in nuclear medicine]A E Sichirollo, E Bombardieri, G Cortona, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 10, 2004
Position of nuclear medicine modalities in the diagnostic work-up of breast cancerJ R Buscombe, B Holloway, N Roche, et al.
Tumori|March 1, 1997
Role of bone scan in breast cancer follow-upL Maffioli, M Zambetti, M R Castellani, et al.
Pageof 24

Showing results (31-40 of 231) with videos related to

Sort By:
Pageof 24
The International Journal of Biological Markers|April 1, 1997
Cost-effectiveness of tumor marker detection in cancer patientsE Bombardieri, S Massaron, A Martinetti, et al.
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1995
Tumour marker evaluation in patients with lung cancerE Seregni, C Botti, A Bogni, et al.
Minerva Medica|September 15, 1975
[Possibilities and limitations of the direct radioimmunological method with double guinea-pig antibody in the detection of serum Australia antigen]A Rodari, R Ringhini, M Parodi, et al.
Tumori|March 1, 1997
The need of cost-effectiveness evaluation when using high-cost equipment in national health servicesE Bombardieri, F Crippa, C Rossetti, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|August 10, 2000
Role of 131I-metaiodobenzylguanidine (MIBG) in the treatment of neuroendocrine tumours. Experience of the National Cancer Institute of MilanM R Castellani, A Chiti, E Seregni, et al.
La Radiologia Medica|September 1, 1977
[Use of bleomycin labeled with In-111 in the diagnosis of neoplasms]A Rodari, A Turrin, E Bombardieri, et al.
La Radiologia Medica|November 1, 1980
[111-In-bleomycin as a positive indicator: evaluation of results in 252 cases controlled by histological diagnosis]E Bombardieri, A Rodari, A Turrin, et al.
La Radiologia Medica|April 6, 1999
[External exposure of hot cell operators in nuclear medicine]A E Sichirollo, E Bombardieri, G Cortona, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 10, 2004
Position of nuclear medicine modalities in the diagnostic work-up of breast cancerJ R Buscombe, B Holloway, N Roche, et al.
Tumori|March 1, 1997
Role of bone scan in breast cancer follow-upL Maffioli, M Zambetti, M R Castellani, et al.
Pageof 24